SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): September 22, 2011 (September 22, 2011)
CHEMBIO DIAGNOSTICS, INC.
(Exact name of registrant as specified in its charter)
|
Nevada
|
0-30379
|
88-0425691
|
||
|
(State or other jurisdiction
|
(Commission File Number)
|
(IRS Employer
|
||
|
of Incorporation)
|
Identification Number)
|
|||
|
3661 Horseblock Road
|
||||
|
Medford, NY 11763
|
||||
|
(Address of principal executive offices)
|
||||
|
631-924-1135
|
||||
|
(Registrant’s Telephone Number)
|
N/A
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
|
|
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
|
|
|
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
|
|
|
|
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Item 5.07 SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS
At the Company’s annual stockholder meeting on September 22, 2011, stockholders elected directors of the Company to serve until the next annual meeting of stockholders or until their respective successors are elected and qualified. Stockholders also ratified the selection of BDO USA LLP as the Company’s independent registered certified accountants to audit the Company’s financial statements as of and for the year ending December 31, 2011, authorized the Board of Directors to determine whether to effect a reverse stock split, in a range from 5 for 1 to 15 for 1, and approved amending the Company’s 2008 Stock Incentive Plan to increase the number of shares covered by 1,000,000
. A tabulation of the matters voted on at this annual stockholder meeting is set forth below.
|
Proposal #1:– Election of Directors
|
Kathy L. Davis
|
Barbara D. DeBuono
|
Peter Kissinger
|
Dr. Gary Meller
|
Lawrence A. Siebert
|
|||||
|
For
|
26,461,602
|
26,601,395
|
26,597,895
|
26,563,295
|
26,563,295
|
|||||
|
Withheld/Against
|
234,148
|
94,355
|
97,855
|
132,455
|
132,455
|
|||||
|
Broker non votes
|
36,607,680
|
36,607,680
|
36,607,680
|
36,607,680
|
36,607,680
|
|
Proposal
|
Ratifying BDO USA LLP as the Company’s Independent Auditors for the year ending December 31, 2011
|
Authorize BOD to determine whether to effect a reverse split
|
|
Approve amendment to the 2008 Stock Incentive Plan
|
Vote to Adjourn Or Postpone the meeting
|
Vote on Other Business
|
||||
|
For
|
55,362,267
|
50,285,361
|
26,514,547
|
51,821,338
|
53,025,978
|
|||||
|
Withheld/Against
|
500
|
4,799,364
|
647,415
|
2,716,117
|
942,317
|
|||||
|
Abstain
|
144,229
|
422,271
|
194,051
|
969,541
|
1,538,701
|
|||||
|
Broker non votes
|
7,796,434
|
7,796,434
|
35,947,417
|
7,796,434
|
7,796,434
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
Date: September 22, 2011 Chembio Diagnostics, Inc.
By: /s/ Lawrence A. Siebert
Lawrence A. Siebert
Chief Executive Officer